Kesimpta, Injektionslösung in Fertigpen

7680677580017 CH-67758 Injektionslösung
Kesimpta, Injektionslösung in Fertigpen
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
1
Selling units
1
Measure
Stück
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
24/07/2026
Patient information leaflet
Français
24/07/2026
Patient information leaflet
Italien
24/07/2026
Summary of Product Characteristics
Allemand
24/07/2026
Summary of Product Characteristics
Français
24/07/2026
Summary of Product Characteristics
Italien
24/07/2026

Detailed composition

Substance Quantity Type Category
ofatumumabum
20.0 MG Substance Wirkstoff (Principe actif)
argininum
- Substance HNIDK
natrii acetas trihydricus
- Substance HNIDK
natrii chloridum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
dinatrii edetas
- Substance HNIDK
acidum hydrochloridum 25 per centum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
0.92 MG Substance HBESI

Reimbursement information

Public price
CHF 1255.55
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/06/2021

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
67758
Drug name
Kesimpta, Injektionslösung in Fertigpen
Galenic form
INLFP
ATC Code
L04AG12
Authorization status
Z
Dispensing category
B
First authorization
01/02/2021
Authorization expiration date
31/12/9999
IT Number
01.99.0.
Domain
Human medicine
Field of application
Multiple Sklerose

Package details

Description (FR)
KESIMPTA sol inj 20 mg/0.4ml stylo pré 0.4 ml
Description (DE)
KESIMPTA Inj Lös 20 mg/0.4ml Fertpen 0.4 ml
Market launch
01/02/2021
Narcotic (BTM)
No
Buy us a coffee Explore the data